Another surgical technology story that is long on hypothetical benefits, but short on evidence, quantification, and harms. News organizations owe it to their readers to examine these issues more thoroughly.
A new study has cast doubt on the proposed benefits of moderate alcohol consumption. Using the results as a jumping off point, this story skeptically assesses the evidence and explores concerns about the alcohol/heart health hypothesis.
This is a thorough look at the pros and cons of taking certain drugs that have been shown to reduce the risk of breast cancer. The five stars are well deserved.
Strong where it counts, this FiveThirtyEight story does a fine job of explaining the research on “non-celiac gluten sensitivity” in simple, clear terms. A couple of minor additions would’ve completed the picture for readers.
This story delivers most of what readers need to know about four new studies of stroke treatment — even if it does, at times, get a bit caught up in the excitement surrounding the results.
This story has a useful premise: that many people who think they’re gluten sensitive might actually be reacting to a particular type of carbohydrate that causes gas and bloating. We needed a bit more data and detail to be convinced that this premise holds any merit.
This story gives a bit too much credence to the views of the Brennan family in Glen Rock, New Jersey, and not quite enough to those of a Johns Hopkins pediatrician. A slightly different framing structure would’ve made a big difference for readers.
We wish that more stories would bring some skeptical thinking to their coverage of expensive new hepatitis C treatments. The emphasis on short-term effects obscures the lack of long-term data about benefits.
This story reports on a study which suggests that IUDs and contraceptive implants may work longer than regulators say. It’s an interesting and potentially useful piece of news, which is all the more reason to treat it carefully.